Our findings also provide formal demonstration of the role of p140Cap in directly inhibiting TICs through inhibition of β-Catenin, harnessing this function to anti-tumor regulation of the TME immune response (Fig. 10). This evidence concerns the gene SRCIN1 and neoplasm.